Skip to content
healthcare.dev

Atovaquone

NDC 17856-0631, Atovaquone, suspension, from ATLANTIC BIOLOGICALS CORP..

Product NDC
17856-0631
Status
Listed
Labeler
ATLANTIC BIOLOGICALS CORP.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210692
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0631 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE750 mg/5mL

Pharmacologic classes

Antimalarial [EPC]; Antiprotozoal [EPC]

Package NDCNDC-11Package
17856-0631-11785606310172 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0631-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0631-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f99a8a0c-2b42-4da0-8f5a-e963fc619e8b

Use it

Look up 17856-0631 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0631 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17856-0631. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.